1.
Hope WW, Walsh TJ, Denning DW: The invasive and saprophytic syndromes due to Aspergillus spp.Med Mycol 2005, 43 Suppl 1:S207-38.
2.
Lin SJ, Schranz J, Teutsch SM: Aspergillosis case-fatality rate: systematic review of the literature.Clin Infect Dis 2001, 32:358-366.
3.
Lair-Fulleringer S, Guillot J, Desterke C, Seguin D, Warin S, Bezille A, Chermette R, Bretagne S: Differentiation between isolates of Aspergillus fumigatus from breeding turkeys and their environment by genotyping with microsatellite markers.J Clin Microbiol 2003, 41:1798-1800.
4.
Tell LA: Aspergillosis in mammals and birds: impact on veterinary medicine.Med Mycol 2005, 43 Suppl 1:S71-3.
5.
Latge JP: Aspergillus fumigatus and aspergillosis.Clin Microbiol Rev 1999, 12:310-350.
6.
Philippe B, Ibrahim-Granet O, Prevost MC, Gougerot-Pocidalo MA, Sanchez Perez M, Van der Meeren A, Latgé JP: Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates.Infect Immun 2003, 71:3034-3042.
7.
Ibrahim-Granet O, Philippe B, Boleti H, Boisvieux-Ulrich E, Grenet D, Stern M, Latgé JP: Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages.Infect Immun 2003, 71:891-903.
8.
Wasylnka JA, Moore MM: Aspergillus fumigatus conidia survive and germinate in acidic organelles of A549 epithelial cells.J Cell Sci 2003, 116:1579-1587.
9.
Yang Z, Jaeckisch M, Mitchell CG: Enhanced binding of Aspergillus fumigatus spores to A549 epithelial cells and extracellular matrix proteins by a component from the spore surface and inhibition by rat lung lavage fluid.Thorax 2000, 55:579-584.
10.
Cordonnier C, Gilain L, Ricolfi F, Deforges L, Girard-Pipau F, Poron F, Millepied MC, Escudier E: Acquired ciliary abnormalities of nasal mucosa in marrow recipients.Bone Marrow Transplantation 1996, 17:611-616.
11.
Botterel F, Cordonnier C, Barbier V, Wingerstmann L, Liance M, Coste A, Escudier E, Bretagne S: Aspergillus fumigatus causes in vitro electrophysiological and morphological modifications in human nasal epithelial cells.Histol Histopathol 2002, 17:1095-1101.
12.
Papon JF, Coste A, Gendron MC, Cordonnier C, Wingerstmann L, Peynegre R, Escudier E: HLA-DR and ICAM-1 expression and modulation in epithelial cells from nasal polyps.Laryngoscope 2002, 112:2067-2075.
13.
Bart-Delabesse E, Humbert JF, Delabesse E, Bretagne S: Microsatellite markers for typing Aspergillus fumigatus isolates.J Clin Microbiol 1998, 36:2413-2418.
14.
Bart-Delabesse E, Cordonnier C, Bretagne S: Usefulness of genotyping with microsatellite markers to investigate hospital-acquired invasive aspergillosis.J Hosp Infect 1999, 42:321-327.
15.
Nielsen PV, Beuchat LR, Frisvad JC: Growth of and fumitremorgin production by Neosartorya fischeri as affected by temperature, light, and water activity.Appl Environ Microbiol 1988, 54:1504-1510.
16.
Rundberget T, Wilkins AL: Determination of Penicillium mycotoxins in foods and feeds using liquid chromatography-mass spectrometry.J Chromatogr A 2002, 964:189-197.
17.
Amitani R, Murayama T, Nawada R, Lee WJ, Niimi A, Suzuki K, Tanaka E, Kuze F: Aspergillus culture filtrates and sputum sols from patients with pulmonary aspergillosis cause damage to human respiratory ciliated epithelium in vitro.Eur Respir J 1995, 8:1681-1687.
18.
Amitani R, Taylor G, Elezis EN, Llewellyn-Jones C, Mitchell J, Kuze F, Cole PJ, Wilson R: Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium.Infect Immun 1995, 63:3266-3271.
19.
Belkacemi L, Barton RC, Hopwood V, Evans EG: Determination of optimum growth conditions for gliotoxin production by Aspergillus fumigatus and development of a novel method for gliotoxin detection.Med Mycol 1999, 37:227-233.
20.
Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP, Prince RA: Detection of gliotoxin in experimental and human aspergillosis.Infect Immun 2005, 73:635-637.
21.
Bauer J, Gareis M, Bott A, Gedek B: Isolation of a mycotoxin (gliotoxin) from a bovine udder infected with Aspergillus fumigatus.J Med Vet Mycol 1989, 27:45-50.
22.
Cole RJ, Cox RH: Handbook of toxic fungal metabolites.New-York, N.Y., Academic Press; 1981:p 368-373.
23.
Knaus HG, McManus OB, Lee SH, Schmalhofer WA, Garcia-Calvo M, Helms LM, Sanchez M, Giangiacomo K, Reuben JP, Smith AB 3rd: Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels.Biochemistry 1994, 33:5819-5828.
24.
Bikson M, Baraban SC, Durand DM: Conditions sufficient for nonsynaptic epileptogenesis in the CA1 region of hippocampal slices.J Neurophysiol 2002, 87:62-71.
25.
Sabater-Vilar M, Nijmeijer S, Fink-Gremmels J: Genotoxicity assessment of five tremorgenic mycotoxins (fumitremorgen B, paxilline, penitrem A, verruculogen, and verrucosidin) produced by molds isolated from fermented meats.J Food Prot 2003, 66:2123-2129.
26.
Chazalet V, Debeaupuis JP, Sarfati J, Lortholary J, Ribaud P, Shah P, Cornet M, Vu Thien H, Gluckman E, Brucker G, Latgé JP: Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings.J Clin Microbiol 1998, 36:1494-1500.
27.
Debeaupuis JP, Sarfati J, Chazalet V, Latgé JP: Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus.Infect Immun 1997, 65:3080-3085.
28.
Kosalec I, Klaric MS, Pepelljnjak S: Verruculogen production in airborene and clinical isolates of Aspergillus fumigatus Fres.Acta Pharm 2005, 55:357-364.
29.
Tepsic K, Gunde-Cimerman N, Frisvad JC: Growth and mycotoxin productionby Aspergillus fumigatus strains isolated from a saltern.FEMS Microbiology Letters 1997, 157:9-12.
30.
Casadevall A, Pirofski LA: Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity.Infect Immun 1999, 67:3703-3713.
31.
Hissen AH, Wan AN, Warwas ML, Pinto LJ, Moore MM: The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence.Infect Immun 2005, 73:5493-5503.
32.
Schrettl M, Bignell E, Kragl C, Joechl C, Rogers T, Arst HN Jr., Haynes K, Haas H: Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence.J Exp Med 2004, 200:1213-1219.
33.
Fischer G, Muller T, Schwalbe R, Ostrowski R, Dott W: Species-specific profiles of mycotoxins produced in cultures and associated with conidia of airborne fungi derived from biowaste.Int J Hyg Environ Health 2000, 203:105-116.
34.
Panaccione DG, Coyle CM: Abundant respirable ergot alkaloids from the common airborne fungus Aspergillus fumigatus.Appl Environ Microbiol 2005, 71:3106-3111.
35.
Guidance for Industry Bioanalytical Method Validation[http://www.fda.gov/cder/guidance/4252fnl.htm]
36.
Gruenert DC, Finkbeiner WE, Widdicombe JH: Culture and transformation of human airway epithelial cells.Am J Physiol 1995, 268:L347-360.
37.
Rennard SI, Romberger DJ, Sisson JH, Von Essen SG, Rubinstein I, Robbins RA, Spurzem JR: Airway epithelial cells: functional roles in airway disease.Am J Respir Crit Care Med 1994, 150:S27-30.
38.
Richard JL, Lyon RL, Fichtner RE, Ross PF: Use of thin layer chromatography for detection and high performance liquid chromatography for quantitating gliotoxin from rice cultures of Aspergillus fumigatus Fresenius.Mycopathologia 1989, 107:145-151.
39.
Frisvad JC: High-performance liquid chromatographic determination of profiles of mycotoxins and other secondary metabolites.J Chromatogr 1987, 392:333-347.
40.
Boland S, Baeza-Squiban A, Fournier T, Houcine O, Gendron MC, Chevrier M, Jouvenot G, Coste A, Aubier M, Marano F: Diesel exhaust particles are taken up by human airway epithelial cells in vitro and alter cytokine production.Am J Physiol 1999, 276:L604-13.